SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Roundhill ETF Trust - Roundhill Memory ETF

The Roundhill Memory ETF (DRAM) is trending as investors aggressively position for a multi-year memory supercycle, viewing high-bandwidth memory (HBM) as a structural infrastructure bottleneck for AI scaling rather than a typical commodity trade. Community discussion is heavily focused on long-term supply constraints and the potential for a major valuation rerating across the sector, with many investors actively using recent pullbacks to increase exposure ahead of upcoming earnings and industry catalysts.

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is trending due to a significant co-development and licensing partnership with Midjourney that validates its ultrasound-on-chip technology, driving massive investor interest and speculation regarding potential long-term revenue growth. The community remains sharply divided, with bulls pointing to the company's advanced AI capabilities and platform scalability as a sign of future rerating, while bears warn of potential share offerings and volatility typical of the stock's historical pump-and-dump patterns.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is gaining momentum following a new joint research agreement with Honda, which confirms the solid-state battery platform has cleared rigorous technical evaluations and testing by a major automotive OEM. Investors and community members are interpreting this validation as a crucial de-risking event that expands the companys ecosystem beyond its existing partnership with Volkswagen, fueling active discussion about potential scaling timelines and future announcements from additional automakers.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

iShares Silver Trust (SLV) is facing heavy selling pressure as investors grapple with a strengthening dollar and uncertainty surrounding interest rate policy. The community remains deeply divided, with some traders pointing to industrial demand from AI and solar sectors as long-term catalysts, while others label the decline a "bag holder" trap and advocate for physical bullion over ETF shares.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending following reports of a partnership with Apple to design and manufacture chips domestically, a development actively promoted by political leadership. Community sentiment is deeply divided, with some investors celebrating the stock's surge as a major turnaround validation, while others label the news as recycled or a form of market manipulation.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is trending as investors aggressively bid up memory and storage stocks, driven by reports of persistent supply constraints and major hardware price hikes. The community remains deeply polarized, with bulls pointing to the ongoing AI infrastructure supercycle while vocal bears argue the stock's parabolic ascent represents an overextended bubble nearing a potential crash.

Accenture is a global professional services company that helps the world’s businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services, creating tangible value at speed and scale. The firm combines technology and leadership in cloud, data and AI with industry experience, functional expertise and global delivery capability. Its services include Strategy & Consulting, Technology, Operations, Industry X, and Song. It operates through the following geographical segments: North America, EMEA, and Growth Markets. The company was founded in 1989 and is headquartered in Dublin, Ireland.

Accenture plc - Ordinary Shares - Class A

Accenture is currently trending following a significant valuation reset and a downward revision of its revenue growth outlook, fueling intense community debate over whether AI disruption represents an existential threat to the IT consulting business model. Investors are actively split, with some viewing the stock as a deeply undervalued dividend opportunity while others remain skeptical, citing concerns over management strategy, margin pressure, and the long-term necessity of traditional billable-hour services in an AI-driven market.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle is experiencing high volatility as investors balance excitement over stablecoin adoption and the potential Clarity Act with broader market rotations away from crypto-linked assets. The community is deeply divided, with some traders focused on short-term price swings and technical levels, while others remain committed to the long-term potential of USDC in global financial infrastructure.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and social media users fiercely debate the administration's recent memorandum with Iran, with critics labeling it a strategic failure and a massive financial liability. The community remains deeply polarized, with intense arguments centered on the geopolitical impact, the transparency of the deal's terms, and the broader implications for US foreign policy and market stability.

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals is currently seeing significant community interest driven by anticipation of their upcoming earnings report, which has been strategically pulled forward by one week. Investors are closely monitoring strong prescription growth for VOQUEZNA and positive clinical data, while actively discussing the potential for a short squeeze given the substantial short interest and tightening float.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nasdaq, S&P 500 Futures Gain Ahead Of Kevin Warsh’s First Fed Meeting: Why SPCX, ASTS, INTC, MU, SOFI, SMCI Are In Focus

Equity

Stocktwits data showed retail sentiment has improved to ‘bullish’ on SPY and ‘neutral’ on QQQ from ‘bearish’ earlier in the week.

The Multi-Billion-Dollar Race to Defeat Glioblastoma: Why Investors Are Watching One of Oncology's Most Challenging Frontiers

Cancer treatment has advanced dramatically over the past two decades. Precision medicine, immunotherapy, antibody-drug conjugates, and targeted therapies have transformed outcomes for patients across multiple tumor types. $NTHI, $KZIA, $BNTX, $IBRX

ImmunityBio Presents New Clinical and Comparative Data Across Lung and Bladder Cancer at ASCO 2026

ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced two poster presentations and one online publication at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29-June 2, 2026, in Chicago. The presentations span two randomized...

IBRX and the BCG Shortage: Deals That Could Expand Demand

ImmunityBio targets the BCG shortage with new supply deals and label expansion efforts that could strengthen Anktiva demand in bladder cancer.

IBRX Stock Outlook After Q1 Results and a New FDA Review

ImmunityBio eyes a steadier path after a 290% YTD surge as investors watch Anktiva demand, FDA review timing and execution risks.

ImmunityBio: Anktiva Explained and What Comes Next

IBRX's Anktiva drives a 668% revenues jump in 2025 as ImmunityBio expands bladder cancer approvals and pursues new catalysts.

The $13 Million Company Teaching the Immune System to Hunt Cancer

The $13 Million Company Teaching the Immune System to Hunt Cancer The $13 Million Company Teaching the Immune System to Hunt Cancer PR Newswire NEW YORK, May 29, 2026 Issued on behalf of GT Biopharma, Inc. (NASDAQ: GTBP)Three drugs in human trials. A platform licensed from one of the world's top...

ImmunityBio Deadline Today: Rosen Law Firm Encourages ImmunityBio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ImmunityBio, Inc. (NASDAQ: IBRX) between January 19, 2026 and March 24, 2026, both dates inclusive (the Class Period), of the important May 26, 2026 lead plaintiff deadline in the securities class action...

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 26, 2026 in ImmunityBio, Inc. Lawsuit - IBRX

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 26, 2026 in ImmunityBio, Inc. Lawsuit - IBRX The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 26, 2026 in ImmunityBio, Inc. Lawsuit - IBRX PR Newswire NEW YORK, May 26, 2026 NEW YORK, May 26, 2026...

IBRX FINAL DEADLINE REMINDER: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against ImmunityBio, Inc. (ImmunityBio or the Company) (NASDAQ: IBRX) and reminds investors of the May 26, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has...

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

Investors are monitoring the upcoming June 26 reconstitution as the company graduates to the Russell 1000, anticipating major passive inflows and potential short covering.

Bullish sentiment is building on hopes for upcoming BLA filings, pipeline advancements, and perceived softening in regulatory hurdles under new agency leadership.

Traders are highlighting historically low share availability and increasing borrow rates as catalysts that could trigger a violent squeeze if bullish volume persists.

The community is buzzing over Dr. Patrick's strategic silence, with many viewing the quiet period as a classic precursor to material business announcements.

Current Price	$7.36
Prev Close	$6.99
Open	$7.15
Dividend Yield	0.00%
50-Day Moving Average	$7.54
Beta	1.84
Avg. Volume	14.83M
PE Ratio	-8.18

52-Week High	$12.43
52-Week Low	$1.95
Market Capitalization	$7.32B
EPS (Annual)	-$0.382
Price to Book	-8.41
Revenue Per Employee	$163,947.90

IBRXImmunityBio Inc

Fundamentals

Feed

News

Sentiment

Fundamentals

Info

Latest IBRX News